Launched by Bristol-Myers Squibb France in 2015 with an initial endowment of $10 million, the Fondation for Immuno-Oncology Research funds projects at French research institutes in four areas of focus, including basic research, clinical/translational research, public health/patient pathways and a special focus on pediatric cancer. The first eight projects were awarded funding in June 2016, and the second call for projects was closed in October 2016.
www.fondation-bms.fr